News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
200,617 Results
Type
Article (19173)
Company Profile (92)
Press Release (181340)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (67556)
Career Advice (969)
Deals (9727)
Drug Delivery (58)
Drug Development (24021)
Employer Resources (73)
FDA (2613)
Job Trends (4403)
News (94410)
Policy (5953)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (516)
Accelerated approval (24)
ADA (20)
Adcomms (17)
Allergies (68)
Alliances (16447)
ALS (106)
Alzheimer's disease (708)
Antibody-drug conjugate (ADC) (308)
Approvals (2610)
Artificial intelligence (318)
ASCO (124)
Autoimmune disease (218)
Automation (21)
Bankruptcy (85)
Best Places to Work (2919)
BIO (68)
BIOSECURE Act (20)
Biosimilars (79)
Biotechnology (86)
Bladder cancer (100)
Brain cancer (34)
Breast cancer (291)
Cancer (2664)
Cardiovascular disease (183)
Career advice (813)
Career pathing (32)
CAR-T (246)
CDC (8)
Celiac Disease (1)
Cell therapy (634)
Cervical cancer (17)
Clinical research (21578)
Collaboration (1201)
Company closure (6)
Compensation (422)
Complete response letters (53)
COVID-19 (797)
CRISPR (52)
C-suite (782)
Cystic fibrosis (71)
Data (3485)
Denatured (21)
Depression (65)
Dermatology (36)
Diabetes (190)
Diagnostics (1241)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (239)
Drug pricing (55)
Drug shortages (3)
Duchenne muscular dystrophy (156)
Earnings (17920)
Editorial (39)
Employer branding (8)
Employer resources (76)
Events (35221)
Executive appointments (636)
FDA (3857)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (11)
Frontotemporal dementia (25)
Funding (1010)
Gene editing (136)
Generative AI (38)
Gene therapy (482)
GLP-1 (433)
Government (770)
Grass and pollen (1)
Guidances (94)
Healthcare (2574)
Hematology (80)
HIV (19)
Huntington's disease (47)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (69)
Immunology and inflammation (222)
Immuno-oncology (68)
Indications (64)
Infectious disease (951)
Inflammatory bowel disease (122)
Inflation Reduction Act (3)
Influenza (61)
Intellectual property (130)
Interviews (147)
IPO (4246)
IRA (14)
Job creations (1492)
Job search strategy (714)
JPM (46)
Kidney cancer (8)
Labor market (82)
Layoffs (274)
Leadership (34)
Legal (1232)
Liver cancer (26)
Longevity (18)
Lung cancer (313)
Lymphoma (239)
Machine learning (33)
Management (25)
Manufacturing (584)
Marketing (2)
MASH (72)
Medical device (761)
Medtech (772)
Mergers & acquisitions (6000)
Metabolic disorders (634)
mRNA (128)
Multiple sclerosis (93)
NASH (8)
Neurodegenerative disease (260)
Neuropsychiatric disorders (55)
Neuroscience (1470)
Neurotech (1)
NextGen: Class of 2026 (1503)
Non-profit (512)
Now hiring (55)
Obesity (341)
Opinion (224)
Ovarian cancer (116)
Pain (87)
Pancreatic cancer (143)
Parkinson's disease (199)
Partnered (17)
Patents (252)
Patient recruitment (331)
Peanut (21)
People (23965)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase 1 (8283)
Phase 2 (10306)
Phase 3 (5798)
Pipeline (3790)
Policy (161)
Postmarket research (308)
Preclinical (3421)
Press Release (63)
Prostate cancer (99)
Psychedelics (40)
Radiopharmaceuticals (127)
Rare diseases (613)
Real estate (2492)
Recruiting (42)
Regulatory (5951)
Reports (27)
Research institute (559)
Resumes & cover letters (157)
Rett syndrome (24)
RNA editing (21)
RSV (30)
Schizophrenia (44)
Series A (218)
Series B (135)
Service/supplier (4)
Sickle cell disease (49)
Special edition (20)
Spinal muscular atrophy (60)
Sponsored (17)
Startups (1865)
State (1)
Stomach cancer (7)
Supply chain (46)
Tariffs (40)
The Weekly (69)
Vaccines (425)
Venture capital (124)
Weight loss (201)
Women's health (37)
Worklife (11)
Date
Last 7 days (184)
Last 30 days (836)
Last 365 days (12224)
2026 (6801)
2025 (11965)
2024 (12708)
2023 (13341)
2022 (16151)
2021 (17027)
2020 (13264)
2019 (9685)
2018 (7718)
2017 (9036)
2016 (8194)
2015 (9492)
2014 (9758)
2013 (9494)
2012 (6126)
2011 (6505)
2010 (5885)
Location
Africa (338)
Alabama (63)
Alaska (3)
Arizona (83)
Arkansas (3)
Asia (15091)
Australia (2863)
California (5445)
Canada (1465)
China (784)
Colorado (120)
Connecticut (193)
Delaware (129)
Europe (32878)
Florida (700)
Georgia (87)
Hawaii (2)
Idaho (14)
Illinois (284)
India (44)
Indiana (282)
Iowa (9)
Japan (236)
Kansas (25)
Kentucky (9)
Louisiana (7)
Maine (2)
Maryland (683)
Massachusetts (4331)
Michigan (127)
Minnesota (249)
Mississippi (1)
Missouri (37)
Montana (12)
Nebraska (5)
Nevada (49)
New Hampshire (10)
New Jersey (1186)
New Mexico (11)
New York (1311)
North Carolina (728)
North Dakota (6)
Northern California (2696)
Ohio (127)
Oklahoma (11)
Oregon (11)
Pennsylvania (1017)
Puerto Rico (13)
Rhode Island (19)
South America (411)
South Carolina (11)
Southern California (2211)
Tennessee (39)
Texas (805)
United States (18044)
Utah (80)
Vermont (1)
Virginia (50)
Washington D.C. (24)
Washington State (645)
West Virginia (1)
Wisconsin (40)
200,617 Results for "nanjing legend biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
CAR-T
Legend soars on ‘best-in-class,’ ‘best-in-disease’ in vivo CAR T in early lymphoma study
All six non-Hodgkin lymphoma patients on Legend Biotech’s CAR T therapy responded to treatment—findings that could make the biotech an attractive takeover target, according to analysts at Oppenheimer.
June 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Legend Biotech Corporation Announces Pricing of Public Offering - June 17, 2026
June 18, 2026
·
4 min read
Press Releases
Legend Biotech Corporation Announces Proposed Public Offering - June 17, 2026
June 18, 2026
·
4 min read
Press Releases
Legend Biotech Announces Presentations at ASCO 2026
May 22, 2026
·
29 min read
Press Releases
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
May 12, 2026
·
13 min read
Press Releases
Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
May 4, 2026
·
6 min read
Press Releases
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
April 28, 2026
·
1 min read
Press Releases
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
June 15, 2026
·
9 min read
Earnings
Biotechs Report Regulatory Headaches, High-Stakes Catalysts During Q4 Earnings
Dozens of biotechs reported earnings this week.
BioSpace
recaps key highlights from Capricor Therapeutics, Legend Biotech, Inovio and Allogene.
March 13, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
June 1, 2026
·
30 min read
1 of 20,062
Next
